Coagulopathy and hemostasis management in patients undergoing liver transplantation
Open Access
- 13 May 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 28 (10) , 1651-1663
Abstract
Patients with acute and chronic liver disease present with a wide range of disease states and severity that may require liver transplantation (LT). Physiologic alterations occur that are dynamic throughout all phases of perioperative care, creating complex management scenarios that necessitate multidisciplinary clinical care. Specifically, alterations in hemostasis in liver disease can be pronounced and evolve with disease progression over time. Recent studies and society guidance address this emerging paradigm and offer recommendations to assist with hemostatic management in patients with liver disease. However, patients undergoing LT are unique and diverse, often with unstable disease that requires specialized approaches. Our aim is to provide a focused review of hemostatic management of the LT patient, distinguish unique aspects of the three main phases of care (before LT, perioperative, and after LT), and identify knowledge gaps and critical areas of future research.Keywords
Funding Information
- National Cancer Institute (1R01CA233878.)
This publication has 107 references indexed in Scilit:
- The Coagulopathy of Chronic Liver DiseaseNew England Journal of Medicine, 2011
- Vascular Stents in the Management of Portal Venous Complications in Living Donor Liver TransplantationAmerican Journal of Transplantation, 2010
- Vascular Complications After Deceased and Living Donor Liver Transplantation: A Single-Center ExperienceTransplantation Proceedings, 2010
- Long-term efficacy of stent placement for treating inferior vena cava stenosis following liver transplantationLiver Transplantation, 2010
- Coagulation Defects Do Not Predict Blood Product Requirements During Liver TransplantationTransplantation, 2008
- Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinomaThrombosis Research, 2008
- Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosisHepatology, 2007
- Efficacy and Safety of Antifibrinolytic Drugs in Liver Transplantation: A Systematic Review and Meta-AnalysisAmerican Journal of Transplantation, 2007
- Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests†‡Hepatology, 2005
- Coagulation Disorders in Liver DiseaseSeminars in Liver Disease, 2002